A Mechanic’s Vision: The OdonAssist™ Device (...

ACOG first recommended antiviral suppressive therapy at 36 weeks of gestation for women with a history of genital herpes in 2007, with the publication of Practice Bulletin No. 82 ("Management of Herpes in Pregnancy," June 2007). This was the first ACOG practice bulletin specifica ...  Show more

Today, we’re diving straight into a topic that hits close to home for millions of patients and providers alike: IUD insertion pain, and more importantly, how we can actually make it better. Now, if you’ve been practicing or following clinical guidelines for a while, you know the ...  Show more

Content Warning: This episode includes mentions of miscarriage, pregnancy loss, pregnancy complications, traumatic birth experiences, and other potentially disturbing topics related to childbirth, pregnancy, and the postpartum period. In Act 3 of our pregnancy series, we arrive a ...  Show more

Dr. Adam Striker and Dr. Alyssa Brzenski, editor for Summaries of Emerging Evidence (SEE), examine two recent studies featured in the 40A issue. Listen in as they discuss a study of the use of a prophylactic methylergonovineduring intrapartum cesarean birth, and a second study ...

In this episode, we review the high-yield topic of Placenta Previa from the Obstetrics section.

Follow <a href="h ...

ACOG Practice bulletin: # 171 PTL or TPTL:  Preterm <37wks, cervical change Evaluation: SSE first: Collect GC/CT cultures, FFN (no gel, blood or semen), GBS, eval for rupture if needed SVE: Cervical change–can dilation or effacement changes FFN: Fetal fibronectin If tPTL: Magnesi ...  Show more